Sfoglia per AUTORE
OLIVA E
Collezione AOU Novara

  

Items : 6

Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS). in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2023 Oct 1;41(28):4486-4496. doi: 10.1200/JCO.22.02699. Epub 2023 Jun 9.

2023
ASL Biella
AOU Città della Salute di Torino
AOU Novara
AO Alessandria

Latagliata R; Zini G; Rizzo L; Bova I; D'Errigo MG; Cufari P; Arcadi MT; Delfino IM; Liberati AM; Candoni A; Rivellini F; Buccisano F; Stamatoullas-Bastard A; Ricco A; Palumbo GA; Impera S; Di Renzo N; Fenaux P; Germing U; Molteni A; Bocchia M; Beltrami G; Russo E; Castelli A; Fattizzo B; Guarini A; Tripepi G; Iannì G; Reda G; et alii...

Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts. in American journal of hematology / Am J Hematol. 2023 Aug;98(8):E204-E208. doi: 10.1002/ajh.26960. Epub 2023 May 24.

2023
ASL Città di Torino
ASL Torino 4
AO Cuneo
ASL Biella
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara
AO Alessandria

Della Porta MG; Pasini P; Naldi I; Finelli C; Giordano L; Turrini M; Tanasi I; Tosi P; Selleri C; Marchetti M; Norata M; Frigeni M; Sancetta R; Fianchi L; Galimberti S; Grimaldi D; Ferrara F; Castelli A; Di Veroli A; Di Bona E; Calvisi A; Rivoli G; Bono R; Nicolino B; Occhini U; Molteni A; Guarini A; Genua A; Diral E; et alii...

Multicenter Italian Study on "In Vitro Activities" of Isavuconazole, Voriconazole, Amphotericin B, and Caspofungin for Aspergillus Species: Comparison between Sensititre(TM) YeastOne(TM) and MIC Test Strip. in Infection and drug resistance / Infect Drug Resist. 2022 Oct 4;15:5839-5848. doi: 10.2147/IDR.S367082. eCollection 2022.

2022
AOU Novara

Lo Cascio G; Bazaj A; Trovato L; Sanna S; Andreoni S; Blasi E; Conte M; Fazii P; Oliva E; Lepera V; Lombardi G; Farina C;

Overall survival of myelodysplastic syndrome patients after azacitidine discontinuation and applicability of the North American MDS Consortium scoring system in clinical practice. in Cancer / Cancer. 2021 Jun 15;127(12):2015-2024. doi: 10.1002/cncr.33472. Epub 2021 Mar 19.

2021
ASL Torino 4
ASL Biella
AOU Città della Salute di Torino
AOU Novara

Castelli A; Santini V; Angelucci E; Musto P; Capalbo SF; Abbadessa A; Alesiani F; Catarini M; Oliva EN; Centurioni R; Bigazzi C; Zambello R; Crugnola M; Fanin R; Cilloni D; Di Tucci AA; Freilone R; Cametti G; Danise P; Selleri C; Poloni A; Finelli C; Balleari E; Ferrero D; Allione B; Salvi F; Ceccarelli M; Guolo F; Miglino M; et alii...

Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia. in Blood / Blood. 2021 Aug 19;138(7):571-583. doi: 10.1182/blood.2021010735.

2021
AOU Città della Salute di Torino
AOU Novara

Vianelli N; Zaja F; De Stefano V; Rodeghiero F; Mazzucconi MG; Cavo M; Sutto E; Carpenedo M; Carli G; Nicolosi D; Baldacci E; Auteri G; Borchiellini A; Giuffrida G; Caocci G; Chiurazzi F; Consoli U; Cantoni S; Oliva EN; Barcellini W; Patriarca A; Rivolti E; Carrai V; Bartoletti D; Ferretti A; Ruggeri M; Lucchini E; Palandri F; Rossi E; et alii...

SARS-CoV-2 in Myelodysplastic Syndromes: A Snapshot From Early Italian Experience. in HemaSphere / Hemasphere. 2020 Sep 23;4(5):e483. doi: 10.1097/HS9.0000000000000483. eCollection 2020 Oct.

2020
ASL Torino 5
ASL Biella
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
ASL Città di Torino
ASL Torino 4
AO Alessandria
AOU Novara

Santini V; Tafuri A; Selleri C; Rivellini F; Secchi R; Sciumé M; Sarlo C; Riva M; Poloni A; Pilo F; Pelizzari A; Palumbo GA; Musto P; Oliva E; Messa E; Niscola P; Molteni A; Mancini S; Frattini F; Gaidano V; Guaragna G; Latagliata R; Gumenyuk S; Finelli C; Giai V; Fianchi L; Filì C; Ferrara IL; Fava C; et alii...